IMNM Immunome, Inc. - Common Stock
$20,33
Fiyat · May 20, 2026
Temel veriler itibarıyla May 12, 2026
52 Haftlık Aralık
$8–$28
63% of range
Analist Derecelendirmesi
BUY
20 analysts
Fiyat Hedefi
$35
+73% upside
P/E (TTM)
-8.8
ROE
-47.0%
Net Kâr Marjı
-3060.0%
IMNM Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$20.32
Piyasa Değeri
$2.43B
P/E (TTM)
-8.8
EPS (TTM)
$-2.43
Gelir (TTM)
$7M
Temettü Verimi
—
ROE
-47.0%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$8 – $28
IMNM Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$7M
2023-12-31
→
2025-12-31
Hisse Başına Kâr
$-2.43
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$-201M
2020-12-31
→
2025-12-31
Marjlar
-3060.0%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
IMNM
Akran Ortalaması
P/E (TTM)
-8.8
11.3
P/S (TTM) (F/S (TTM))
350.1
22.0
P/B (F/D)
3.8
6.3
Price / FCF (Fiyat / Serbest Nakit Akışı)
-12.1
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
IMNM
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-3228.8%
—
Net Profit Margin (Net Kâr Marjı)
-3060.0%
-74.2%
ROA
-46.0%
-30.3%
ROE
-47.0%
-42.3%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
IMNM
Akran Ortalaması
Current Ratio (Cari Oran)
14.7
8.0
Quick Ratio (Cari Oran)
14.5
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
IMNM
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-23.2%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
IMNM
Akran Ortalaması
IMNM Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
20 analist
- Güçlü Al 6 30,0%
- Al 13 65,0%
- Tut 1 5,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
13 analist · 2026-05-19
Medyan
$35.00
← Tüm hedeflerin altında
$20.32
Düşük
$30.00
Yüksek
$40.00
Medyan hedef
$35.00
+72,2%
Ortalama hedef
$35.23
+73,3%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.02%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.48 | $-0.57 | 0.09% |
| 31 Aralık 2025 | $-0.76 | $-0.61 | -0.15% |
| 30 Eylül 2025 | $-0.65 | $-0.59 | -0.06% |
| 30 Haziran 2025 | $-0.50 | $-0.54 | 0.04% |
| 31 Mart 2025 | $-0.52 | $-0.69 | 0.17% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| VERA | — | -10.9 | — | — | -55.9% | — |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | — |
| MLYS | $2.96B | -15.8 | — | — | -32.2% | — |
| KOD | $1.73B | -6.5 | — | — | -202.0% | — |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 12
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $7M | $9M | $14M | |
| R&D Expense | $177M | $130M | $23M | |
| SG&A Expense | $44M | $33M | $20M | |
| Operating Expenses | $231M | $315M | $124M | |
| Operating Income | $-224M | $-306M | $-110M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-212M | $-293M | $-107M | |
| EPS (Basic) | $-2.43 | $-5.00 | $-5.38 | |
| EPS (Diluted) | $-2.43 | $-5.00 | $-5.38 | |
| Shares (Basic) | 87,350,956 | 58,639,441 | 19,843,651 | |
| Shares (Diluted) | 87,350,956 | 58,639,441 | 19,843,651 | |
| EBITDA | $-222M | $-304M | $-109M |
Bilanço 19
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $653M | $143M | $99M | |
| Prepaid Expense | $7M | $4M | $7M | |
| Current Assets | $661M | $221M | $145M | |
| PP&E (Net) | $15M | $10M | $2M | |
| Other Non-current Assets | $5M | $4M | $100.0K | |
| Total Assets | $683M | $240M | $149M | |
| Accounts Payable | $3M | $14M | $3M | |
| Current Liabilities | $45M | $54M | $22M | |
| Capital Leases | $4M | $5M | $1M | |
| Deferred Tax | $801.0K | $1M | $378.0K | |
| Other Non-current Liabilities | · | · | $1M | |
| Total Liabilities | $49M | $59M | $29M | |
| Common Stock | $11.0K | $6.0K | $4.0K | |
| Paid-in Capital | $1.36B | $697M | $343M | |
| Retained Earnings | $-728M | $-516M | $-223M | |
| AOCI | $0 | $57.0K | $22.0K | |
| Stockholders' Equity | $634M | $181M | $120M | |
| Liabilities + Equity | $683M | $240M | $149M | |
| Shares Outstanding | 113,133,199 | 64,460,829 | 43,251,778 |
Nakit Akışı 11
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $2M | $457.0K | |
| Stock-based Comp | $26M | $16M | $6M | |
| Other Non-cash | $-7M | $165M | $93M | |
| Operating Cash Flow | $-191M | $-111M | $-8M | |
| CapEx | $10M | $7M | $831.0K | |
| Investing Cash Flow | $61M | $-85M | $-30M | |
| Stock Issued | $46M | $20M | $34.0K | |
| Net Stock Activity | $46M | $20M | $34.0K | |
| Financing Cash Flow | $640M | $241M | $116M | |
| Net Change in Cash | $510M | $45M | $78M | |
| Free Cash Flow | $-201M | $-118M | $-8M |
Kârlılık 5
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -3228.8% | -3382.4% | -781.4% | |
| Net Margin | -3060.0% | -3240.4% | -761.9% | |
| EBITDA Margin | -3193.3% | -3365.0% | -778.1% | |
| ROA | -46.0% | -150.7% | -123.8% | |
| ROE | -47.0% | -147.9% | -169.6% |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 14.7 | 4.1 | 6.6 | |
| Quick Ratio | 14.5 | 2.6 | 4.5 |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.2 |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -23.2% | -35.5% | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $7M | $9M | $14M | |
| Net Income TTM | $-212M | $-293M | $-107M | |
| Market Cap | $2.43B | $685M | $463M | |
| P/E | -8.8 | -2.1 | -2.0 | |
| P/S | 350.1 | 75.7 | 33.0 | |
| P/B | 3.8 | 3.8 | 3.9 | |
| P / Tangible Book | 3.8 | 3.8 | 3.9 | |
| P / Cash Flow | -12.7 | -6.2 | -61.2 | |
| P / FCF | -12.1 | -5.8 | -55.1 | |
| Earnings Yield | -11.3% | -47.1% | -50.3% |
Gelir Tablosu 11
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $4M | $3M | $3M | $3M | $2M | $1M | $4M | $4M | $4M | $2M | |
| R&D Expense | $46M | $51M | $49M | $40M | $37M | $48M | $37M | $29M | $15M | $10M | $4M | $6M | $4M | |
| SG&A Expense | $13M | $12M | $11M | $10M | $11M | $10M | $10M | $7M | $6M | $8M | $4M | $4M | $3M | |
| Operating Expenses | $59M | $73M | $60M | $50M | $48M | $86M | $53M | $42M | $133M | $98M | $8M | $10M | $7M | |
| Operating Income | $-59M | $-73M | $-60M | $-46M | $-45M | $-83M | $-51M | $-40M | $-132M | $-95M | $-5M | $-6M | $-4M | |
| Net Income | $-54M | $-70M | $-57M | $-43M | $-42M | $-80M | $-47M | $-36M | $-129M | $-93M | $-4M | $-6M | $-4M | |
| EPS (Basic) | $-0.48 | $-0.76 | $-0.65 | $-0.50 | $-0.52 | $-1.11 | $-0.78 | $-0.60 | $-2.51 | $-4.21 | $-0.36 | $-0.46 | $-0.35 | |
| EPS (Diluted) | $-0.48 | $-0.76 | $-0.65 | $-0.50 | $-0.52 | $-1.11 | $-0.78 | $-0.60 | $-2.51 | $-4.21 | $-0.36 | $-0.46 | $-0.35 | |
| Shares (Basic) | 113,136,836 | -167,028,008 | 87,957,868 | 87,010,742 | 79,410,354 | -113,046,972 | 60,205,327 | 59,936,703 | 51,544,383 | -16,738,963 | 12,202,335 | 12,197,801 | 12,182,478 | |
| Shares (Diluted) | 113,136,836 | -167,028,008 | 87,957,868 | 87,010,742 | 79,410,354 | -113,046,972 | 60,205,327 | 59,936,703 | 51,544,383 | -16,738,963 | 12,202,335 | 12,197,801 | 12,182,478 | |
| EBITDA | $-59M | · | $-60M | $-46M | $-44M | · | $-51M | $-40M | $-132M | · | $-5M | $-6M | $-4M |
Bilanço 19
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $583M | $653M | $273M | $144M | $258M | $143M | $156M | $165M | $270M | $99M | $91M | $38M | $44M | |
| Prepaid Expense | $12M | $7M | $7M | $9M | $6M | $4M | $4M | $6M | $4M | $7M | $773.0K | $1M | $2M | |
| Current Assets | $594M | $661M | $280M | $277M | $323M | $221M | $244M | $284M | $313M | $145M | $91M | $40M | $47M | |
| PP&E (Net) | $17M | $15M | $12M | $11M | $11M | $10M | $7M | $6M | $4M | $2M | $1M | $1M | $916.0K | |
| Other Non-current Assets | $5M | $5M | $5M | $4M | $4M | $4M | $3M | $3M | $568.0K | $100.0K | · | · | · | |
| Total Assets | $620M | $683M | $299M | $296M | $343M | $240M | $257M | $296M | $320M | $149M | $93M | $41M | $48M | |
| Accounts Payable | $6M | $3M | $6M | $5M | $9M | $14M | $4M | $7M | $7M | $3M | $3M | $4M | $3M | |
| Current Liabilities | $27M | $45M | $31M | $23M | $31M | $54M | $40M | $40M | $31M | $22M | $23M | $26M | $25M | |
| Capital Leases | $4M | $4M | $4M | $4M | $5M | $5M | $2M | $2M | $1M | $1M | · | · | · | |
| Deferred Tax | · | $801.0K | · | · | · | $1M | · | · | · | $378.0K | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $122.0K | · | · | |
| Total Liabilities | $31M | $49M | $35M | $27M | $36M | $59M | $42M | $42M | $34M | $29M | $87M | $32M | $34M | |
| Common Stock | $11.0K | $11.0K | $9.0K | $9.0K | $9.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $1.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.37B | $1.36B | $922M | $870M | $865M | $697M | $650M | $642M | $638M | $343M | $136M | $135M | $134M | |
| Retained Earnings | $-782M | $-728M | $-658M | $-601M | $-557M | $-516M | $-436M | $-388M | $-352M | $-223M | $-130M | $-126M | $-120M | |
| AOCI | · | $0 | $0 | $-24.0K | $-3.0K | $57.0K | $70.0K | $2.0K | $4.0K | $22.0K | · | · | · | |
| Stockholders' Equity | $589M | $634M | $264M | $269M | $307M | $181M | $215M | $254M | $286M | $120M | $6M | $9M | $14M | |
| Liabilities + Equity | $620M | $683M | $299M | $296M | $343M | $240M | $257M | $296M | $320M | $149M | $93M | $41M | $48M | |
| Shares Outstanding | 113,171,396 | 113,133,199 | 91,706,948 | 87,012,835 | 86,955,855 | 64,460,829 | 60,422,062 | 60,013,655 | 59,694,243 | 43,251,778 | 12,202,516 | 12,200,433 | 12,194,184 |
Nakit Akışı 11
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $603.0K | $629.0K | $589.0K | $637.0K | $611.0K | $450.0K | $411.0K | $549.0K | $157.0K | $151.0K | $111.0K | $101.0K | $94.0K | |
| Stock-based Comp | $8M | $8M | $7M | $5M | $6M | $5M | $5M | $3M | $2M | $3M | $1M | $1M | $1M | |
| Other Non-cash | $-13M | · | · | · | $-18M | · | · | · | $116M | · | · | · | $27M | |
| Operating Cash Flow | $-59M | $-48M | $-41M | $-49M | $-53M | $-42M | $-34M | $-23M | $-11M | $-17M | $-9M | $-6M | $24M | |
| CapEx | $3M | $4M | $1M | $905.0K | $4M | $1M | $2M | $2M | $2M | $349.0K | $36.0K | $340.0K | $106.0K | |
| Investing Cash Flow | $-12M | $-4M | $124M | $-64M | $5M | $10M | $24M | $-82M | $-37M | $-30M | $-36.0K | $-340.0K | $-106.0K | |
| Stock Issued | · | $0 | · | · | · | $20M | · | · | · | $0 | $0 | $0 | $34.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $34.0K | |
| Financing Cash Flow | $-135.0K | $433M | $45M | $-55.0K | $162M | $20M | $305.0K | $694.0K | $219M | $55M | $61M | $0 | $34.0K | |
| Net Change in Cash | $-71M | $381M | $129M | $-114M | $114M | $-12M | $-10M | $-104M | $171M | $8M | $52M | $-6M | $24M | |
| Free Cash Flow | $-62M | · | · | · | $-57M | · | · | · | $-13M | · | · | · | $24M |
Kârlılık 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1157.6% | -1525.5% | · | -1736.1% | -1692.4% | -12857.1% | · | -130.0% | -135.4% | -189.1% | |
| Net Margin | · | · | · | -1080.9% | -1423.1% | · | -1618.6% | -1528.0% | -12584.3% | · | -121.9% | -130.4% | -180.6% | |
| EBITDA Margin | · | · | · | -1157.6% | -1504.6% | · | -1736.1% | -1692.4% | -12841.8% | · | -130.0% | -135.4% | -185.2% | |
| ROA | -11.2% | · | -20.7% | -14.6% | -12.6% | · | -26.9% | -21.4% | -70.4% | · | -7.0% | -13.8% | -8.9% | |
| ROE | -12.0% | · | -24.0% | -16.6% | -14.1% | · | -42.6% | -27.5% | -86.5% | · | -29.8% | -28.1% | -16.5% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.7 | · | 8.9 | 12.1 | 10.5 | · | 6.2 | 7.1 | 10.2 | · | 4.0 | 1.5 | 1.9 | |
| Quick Ratio | 21.3 | · | 8.7 | 6.3 | 8.4 | · | 3.9 | 4.1 | 8.8 | · | 3.9 | 1.5 | 1.8 |
Verimlilik 1
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 |
Değerleme (TTM) 10
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | · | $10M | $12M | $9M | · | $10M | $11M | $11M | · | · | · | · | |
| Net Income TTM | $-196M | · | $-190M | $-168M | $-254M | · | $-217M | $-176M | $-144M | · | $-23M | $-27M | $-33M | |
| Market Cap | $2.48B | · | $1.07B | $809M | $585M | · | $883M | $726M | $1.47B | · | $102M | $97M | $61M | |
| P/E | -10.2 | · | -4.8 | -3.9 | -1.5 | · | -3.4 | -3.1 | -6.7 | · | -4.3 | -3.4 | -1.8 | |
| P/S | 356.6 | · | 109.0 | 66.2 | 63.4 | · | 89.5 | 64.7 | 131.3 | · | · | · | · | |
| P/B | 4.2 | · | 4.1 | 3.0 | 1.9 | · | 4.1 | 2.9 | 5.2 | · | 16.8 | 10.3 | 4.4 | |
| P / Tangible Book | 4.2 | · | 4.1 | 3.0 | 1.9 | · | 4.1 | 2.9 | 5.2 | · | 16.8 | 10.3 | 4.4 | |
| P / Cash Flow | -42.2 | · | · | · | -11.0 | · | · | · | -131.9 | · | · | · | 2.5 | |
| P / FCF | -40.2 | · | · | · | -10.3 | · | · | · | -110.5 | · | · | · | 2.5 | |
| Earnings Yield | -9.8% | · | -20.9% | -25.8% | -65.5% | · | -29.1% | -32.5% | -14.9% | · | -23.0% | -29.1% | -56.1% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $7M | $9M | $14M | — | — |
| Faaliyet Kâr Marjı % | -3228.8% | -3382.4% | -781.4% | -738020.0% | 252040.0% |
| Net Gelir | $-212M | $-293M | $-107M | $-37M | $-25M |
| Seyreltilmiş Hisse Başı Kâr | $-2.43 | $-5.00 | $-5.38 | $-3.09 | $-2.14 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 14.7 | 4.1 | 6.6 | 3.1 | 5.8 |
| Cari Oran | 14.5 | 2.6 | 4.5 | 2.8 | 5.1 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-201M | $-118M | $-8M | $-29M | $-18M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.